Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104561142A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104561142A reveals nitrilase biosynthesis for statin intermediates. Offers mild conditions, high yield, and supply chain stability for global pharmaceutical manufacturing.